Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer

S. Nagar, R. P. Remmel

Research output: Contribution to journalReview article

136 Citations (Scopus)

Abstract

The uridine diphosphoglucuronosyltransferases (UGTs) belong to a superfamily of enzymes that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human hepatic and extrahepatic UGT isozymes have been characterized with respect to their substrate specificity, tissue expression and gene structure. Genetic polymorphisms have been identified for almost all the UGT family members. A wide variety of anticancer drugs, dietary chemopreventives and carcinogens are known to be conjugated by members of both UGT1A and UGT2B subfamilies. This review examines in detail each UGT isozyme known to be associated with cancer and carcinogenesis. The cancer-related substrates for several UGTs are summarized, and the functionally relevant genetic polymorphisms of UGTs are reviewed. A number of genotype-phenotype association studies have been carried out to characterize the role of UGT pharmacogenetics in several types of cancer, and these examples are discussed here. In summary, this review focuses on the role of the human UGT genetic polymorphisms in carcinogenesis, chemoprevention and cancer risk.

Original languageEnglish (US)
Pages (from-to)1659-1672
Number of pages14
JournalOncogene
Volume25
Issue number11
DOIs
StatePublished - Mar 13 2006

Fingerprint

Uridine
Pharmacogenetics
Neoplasms
Genetic Polymorphisms
Isoenzymes
Carcinogenesis
Chemoprevention
Genetic Association Studies
Xenobiotics
Substrate Specificity
Carcinogens
Gene Expression
Liver
Enzymes
Pharmaceutical Preparations

Keywords

  • Drug metabolism
  • Genetic polymorphisms
  • Uridine diphosphoglucuronosyltransferase

Cite this

Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. / Nagar, S.; Remmel, R. P.

In: Oncogene, Vol. 25, No. 11, 13.03.2006, p. 1659-1672.

Research output: Contribution to journalReview article

@article{e5dfe563fa8b4cc0813088728b24eb30,
title = "Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer",
abstract = "The uridine diphosphoglucuronosyltransferases (UGTs) belong to a superfamily of enzymes that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human hepatic and extrahepatic UGT isozymes have been characterized with respect to their substrate specificity, tissue expression and gene structure. Genetic polymorphisms have been identified for almost all the UGT family members. A wide variety of anticancer drugs, dietary chemopreventives and carcinogens are known to be conjugated by members of both UGT1A and UGT2B subfamilies. This review examines in detail each UGT isozyme known to be associated with cancer and carcinogenesis. The cancer-related substrates for several UGTs are summarized, and the functionally relevant genetic polymorphisms of UGTs are reviewed. A number of genotype-phenotype association studies have been carried out to characterize the role of UGT pharmacogenetics in several types of cancer, and these examples are discussed here. In summary, this review focuses on the role of the human UGT genetic polymorphisms in carcinogenesis, chemoprevention and cancer risk.",
keywords = "Drug metabolism, Genetic polymorphisms, Uridine diphosphoglucuronosyltransferase",
author = "S. Nagar and Remmel, {R. P.}",
year = "2006",
month = "3",
day = "13",
doi = "10.1038/sj.onc.1209375",
language = "English (US)",
volume = "25",
pages = "1659--1672",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer

AU - Nagar, S.

AU - Remmel, R. P.

PY - 2006/3/13

Y1 - 2006/3/13

N2 - The uridine diphosphoglucuronosyltransferases (UGTs) belong to a superfamily of enzymes that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human hepatic and extrahepatic UGT isozymes have been characterized with respect to their substrate specificity, tissue expression and gene structure. Genetic polymorphisms have been identified for almost all the UGT family members. A wide variety of anticancer drugs, dietary chemopreventives and carcinogens are known to be conjugated by members of both UGT1A and UGT2B subfamilies. This review examines in detail each UGT isozyme known to be associated with cancer and carcinogenesis. The cancer-related substrates for several UGTs are summarized, and the functionally relevant genetic polymorphisms of UGTs are reviewed. A number of genotype-phenotype association studies have been carried out to characterize the role of UGT pharmacogenetics in several types of cancer, and these examples are discussed here. In summary, this review focuses on the role of the human UGT genetic polymorphisms in carcinogenesis, chemoprevention and cancer risk.

AB - The uridine diphosphoglucuronosyltransferases (UGTs) belong to a superfamily of enzymes that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human hepatic and extrahepatic UGT isozymes have been characterized with respect to their substrate specificity, tissue expression and gene structure. Genetic polymorphisms have been identified for almost all the UGT family members. A wide variety of anticancer drugs, dietary chemopreventives and carcinogens are known to be conjugated by members of both UGT1A and UGT2B subfamilies. This review examines in detail each UGT isozyme known to be associated with cancer and carcinogenesis. The cancer-related substrates for several UGTs are summarized, and the functionally relevant genetic polymorphisms of UGTs are reviewed. A number of genotype-phenotype association studies have been carried out to characterize the role of UGT pharmacogenetics in several types of cancer, and these examples are discussed here. In summary, this review focuses on the role of the human UGT genetic polymorphisms in carcinogenesis, chemoprevention and cancer risk.

KW - Drug metabolism

KW - Genetic polymorphisms

KW - Uridine diphosphoglucuronosyltransferase

UR - http://www.scopus.com/inward/record.url?scp=33645120407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645120407&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209375

DO - 10.1038/sj.onc.1209375

M3 - Review article

C2 - 16550166

AN - SCOPUS:33645120407

VL - 25

SP - 1659

EP - 1672

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -